HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Fujii Selected Research

Elements

1/20083-D finite element analysis on brain injury mechanism.
1/2007Finite element analysis of the re-entrant type resonant cavity applicator for brain tumor hyperthermia.
1/20073-D finite element analysis and experimental study on brain injury mechanism.
7/2001Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Fujii Research Topics

Disease

38Neoplasms (Cancer)
01/2017 - 01/2000
20Postoperative Nausea and Vomiting (PONV)
03/2010 - 01/2000
14Carcinoma (Carcinomatosis)
09/2012 - 10/2000
14Vomiting
03/2010 - 01/2000
10Nausea
03/2010 - 01/2000
10Lung Neoplasms (Lung Cancer)
10/2008 - 09/2000
9Pain (Aches)
07/2011 - 04/2000
9Hyperthermia
01/2010 - 01/2001
8Thymoma (Thymic Carcinoma)
09/2005 - 01/2001
7Esophageal Neoplasms (Esophageal Cancer)
10/2015 - 02/2001
7Brain Neoplasms (Brain Tumor)
01/2010 - 01/2007
7Neoplasm Metastasis (Metastasis)
02/2003 - 01/2000
5Fatigue
03/2002 - 12/2000
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2001 - 08/2001
4Brain Injuries (Brain Injury)
01/2010 - 01/2007
4Neuroblastoma
04/2003 - 05/2001
4Ischemia
07/2002 - 03/2000
4Lymphatic Metastasis
12/2001 - 04/2000
3Heart Failure
01/2018 - 12/2001
3Breast Neoplasms (Breast Cancer)
06/2011 - 01/2001
3Pemphigus (Pemphigus Vulgaris)
04/2008 - 11/2000
3Reperfusion Injury
07/2002 - 03/2000
3Body Weight (Weight, Body)
11/2001 - 02/2001
3Schizophrenia (Dementia Praecox)
09/2001 - 09/2000
3Infections
04/2001 - 01/2001
2Cardiomegaly (Heart Hypertrophy)
01/2018 - 11/2016
2Inflammation (Inflammations)
10/2015 - 11/2001
2Osteoarthritis
09/2008 - 01/2000
2IGA Glomerulonephritis (IGA Nephropathy)
01/2008 - 10/2001
2Proteinuria
04/2006 - 08/2001
2Nephrotic Syndrome (Syndrome, Nephrotic)
04/2006 - 12/2001
2Margins of Excision
06/2005 - 01/2001
2Seizures (Absence Seizure)
05/2004 - 01/2000
2Hyperlipidemias (Hyperlipidemia)
12/2001 - 12/2001
2Osteoporosis
11/2001 - 04/2000
2Colonic Neoplasms (Colon Cancer)
10/2001 - 08/2001
2Small Cell Carcinoma
09/2001 - 01/2000
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2001 - 10/2000

Drug/Important Bio-Agent (IBA)

23Messenger RNA (mRNA)IBA
01/2008 - 01/2001
11AntiemeticsIBA
05/2008 - 01/2000
10Granisetron (Kytril)FDA LinkGeneric
06/2001 - 01/2000
9Propofol (Diprivan)FDA LinkGeneric
07/2011 - 06/2000
8Proteins (Proteins, Gene)FDA Link
10/2008 - 03/2000
7Pharmaceutical PreparationsIBA
11/2011 - 12/2000
7Dexamethasone (Maxidex)FDA LinkGeneric
03/2010 - 01/2000
7Analgesics (Analgesic Drugs)IBA
03/2010 - 04/2000
6Metoclopramide (Reglan)FDA LinkGeneric
10/2004 - 01/2000
6Biological ProductsIBA
12/2001 - 04/2000
5AgarIBA
01/2010 - 01/2007
5DroperidolFDA LinkGeneric
03/2001 - 01/2000
4Adenosine Triphosphate (ATP)IBA
11/2011 - 03/2000
4Shape Memory AlloysIBA
01/2010 - 01/2007
4Cell Adhesion MoleculesIBA
04/2008 - 08/2001
4EnzymesIBA
04/2008 - 11/2000
4ElementsIBA
01/2008 - 07/2001
4RNA (Ribonucleic Acid)IBA
01/2008 - 08/2001
4ramosetron (Nasea)IBA
01/2004 - 02/2000
4Matrix Metalloproteinases (MMPs)IBA
02/2003 - 10/2000
4Complementary DNA (cDNA)IBA
10/2001 - 06/2000
3Estrogen ReceptorsIBA
06/2011 - 01/2001
3Indomethacin (Indometacin)FDA LinkGeneric
03/2010 - 01/2008
3EmeticsIBA
03/2010 - 03/2000
3AutoantibodiesIBA
04/2008 - 11/2000
3Cisplatin (Platino)FDA LinkGeneric
01/2008 - 01/2001
3Adrenal Cortex Hormones (Corticosteroids)IBA
07/2005 - 03/2001
3CytokinesIBA
11/2001 - 01/2000
3PeriostinIBA
10/2001 - 08/2001
3Serotonin (5 Hydroxytryptamine)IBA
06/2001 - 01/2001
3AntigensIBA
01/2001 - 01/2000
2pimobendanIBA
01/2018 - 11/2016
2LectinsIBA
01/2017 - 02/2014
2Biomarkers (Surrogate Marker)IBA
10/2014 - 01/2001
2MucinsIBA
10/2011 - 01/2002
2Lidocaine (Xylocaine)FDA LinkGeneric
07/2011 - 06/2000
2Anti-Bacterial Agents (Antibiotics)IBA
01/2010 - 07/2001
2ImmunosorbentsIBA
04/2008 - 11/2000
2DesmogleinsIBA
04/2008 - 11/2001
2Valproic Acid (Depakote)FDA LinkGeneric
03/2008 - 01/2000
2Immunoglobulin A (IgA)IBA
01/2008 - 10/2001
2clobenpropitIBA
05/2004 - 01/2000
2Tissue Inhibitor of Metalloproteinase-1IBA
02/2003 - 06/2001
2olprinoneIBA
03/2002 - 12/2000
2SteroidsIBA
12/2001 - 01/2001
2SodiumIBA
11/2001 - 03/2000
2Indicators and Reagents (Reagents)IBA
11/2001 - 04/2000
2EpitopesIBA
11/2001 - 11/2000
2Irinotecan (Camptosar)FDA LinkGeneric
09/2001 - 01/2000
2beta CateninIBA
08/2001 - 06/2000
2prothymosin alphaIBA
07/2001 - 01/2001
2Histamine (Histamine Dihydrochloride)FDA Link
07/2001 - 01/2000
2Diphenhydramine (Benadryl)FDA LinkGeneric
07/2001 - 01/2000

Therapy/Procedure

15Therapeutics
10/2015 - 01/2000
11Anesthesia
03/2010 - 01/2000
8Drug Therapy (Chemotherapy)
06/2006 - 01/2000
5Laparoscopic Cholecystectomy
03/2010 - 01/2000
3Adrenalectomy
10/2017 - 06/2005
3Radiotherapy
08/2008 - 01/2001
2Esophagectomy
10/2015 - 01/2005
2Blood Transfusion (Blood Transfusions)
01/2010 - 05/2001
2General Anesthesia
01/2004 - 01/2001